An automatic tool for quantification of nerve fibers in corneal confocal microscopy imagesTools Chen, Xin, Graham, Jim, Dabbah, Mohammad, Petropoulos, Ioannis N., Tavakoli, Mitra and Malik, Rayaz (2016) An automatic tool for quantification of nerve fibers in corneal confocal microscopy images. IEEE Transactions on Biomedical Engineering, 64 (4). pp. 786-794. ISSN 0018-9294 Full text not available from this repository.
Official URL: http://ieeexplore.ieee.org/document/7484747/
AbstractObjective: We describe and evaluate an automated software tool for nerve-fiber detection and quantification in corneal confocal microscopy (CCM) images, combining sensitive nerve- fiber detection with morphological descriptors. Method: We have evaluated the tool for quantification of Diabetic Sensorimotor Polyneuropathy (DSPN) using both new and previously published morphological features. The evaluation used 888 images from 176 subjects (84 controls and 92 patients with type 1 diabetes). The patient group was further subdivided into those with (n = 63) and without (n = 29) DSPN. Results: We achieve improved nerve- fiber detection over previous results (91.7% sensitivity and specificity in identifying nerve-fiber pixels). Automatic quantification of nerve morphology shows a high correlation with previously reported, manually measured, features. Receiver Operating Characteristic (ROC) analysis of both manual and automatic measurement regimes resulted in similar results in distinguishing patients with DSPN from those without: AUC of about 0.77 and 72% sensitivity-specificity at the equal error rate point. Conclusion: Automated quantification of corneal nerves in CCM images provides a sensitive tool for identification of DSPN. Its performance is equivalent to manual quantification, while improving speed and repeatability. Significance: CCM is a novel in vivo imaging modality that has the potential to be a noninvasive and objective image biomarker for peripheral neuropathy. Automatic quantification of nerve morphology is a major step forward in the early diagnosis and assessment of progression, and, in particular, for use in clinical trials to establish therapeutic benefit in diabetic and other peripheral neuropathies.
Actions (Archive Staff Only)
|
Tools
Tools
